Ken Rosenthal wears LRF bowtie during interview with Red Sox manager and lymphoma survivor, John Farrell. View The Interview >

LRF's TTAF program provides financial assistance to T-cell lymphoma patients who struggle to pay for transportation costs (e.g., mileage, parking, tolls, gas, train tickets, etc.) to get to and from treatment. More >

FDA approved defibrotide sodium (Defitelio) for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD) following hematopoietic stem-cell transplantation (HSCT). More >

1
2
3

Welcome to Focus on PTCL

The FocusOnPTCL.org website is designed to provide helpful information and resources to patients, caregivers, physicians, and others affected by peripheral T-cell lymphoma (PTCL).

We invite you to browse the site to learn more about PTCL.

Getting the Facts

Peripheral T-cell lymphoma (PTCL) comprises a group of rare and usually aggressive non-Hodgkin lymphomas (NHL) that develop from mature T-cells. Peripheral T-cell lymphoma represents a spectrum of T-cell lymphomas and accounts for approximately 10 percent to 15 percent of all NHL cases in the United States.

Recent Research

Recent research into peripheral T-cell lymphoma has led to significant advancements in the understanding and classification of the disease and its subtypes. Research continues on multiple fronts to develop better treatments for PTCL. We hope you will find the information presented here useful in understanding your disease and discussing it with your physician.

Ask the Doctor

LRF's Ask the Doctor About Lymphoma program is a national series of community based-programs which provide updates on lymphoma and new treatment options for patients.

Youtube

Subscribe to LRF's YouTube Channel for videos on lymphoma, treatment options, and clinical trials. Gain access to in-depth videos with leading lymphoma experts.